retatrutide trial news today Today, we shared new data from two Phase 3 trials of retatrutide, our investigational triple agonist. Learn more: https://go.lilly.com/msrz1v Demand for Unapproved Weight-Loss Drug

Most patients describe the experience as relaxing and restorative

The review concludes that future research must establish evidence-based screening protocols, determine optimal glucose nadir cut-off values for diagnosis, and evaluate long-term outcomes for offspring exposed to maternal hypoglycemia

In clinical trials of Wegovy, alopecia was reported in about 3% of adult patients on the medication versus 1% on placebo

CrossRef Feasibility of terahertz reflectometry for discrimination of human early gastric cancers Young Bin Ji, Chan Hyuk Park, Hyunki Kim, Sang-Hoon Kim, Gyu Min Lee, Sam Kyu Noh, Tae-In Jeon, Joo-Hiuk Son, Yong-Min Huh, Seungjoo Haam, Seung Jae Oh, Sang Kil Lee, Jin-Suck Suh Biomedical Optics Express.2015

After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead